Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02957136 · ClinicalTrials.gov registry record · NA

Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
194
Enrollment target

NCT02957136 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 194 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02957136, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
194 participants
Enrollment target

Study Summary

This is a randomized clinical trial to assess the effect of rapid, near point-of-care testing for multiple common respiratory viruses and bacteria on antibiotic and anti-influenza medication use in emergency department (ED) patients with symptoms of influenza-like illness (ILI) and/or upper respiratory infection (URI).

Interventions

  • DEVICE Rapid respiratory pathogen nucleic acid amplification test

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2016-12-08
Est. Completion 2018-04-30
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT02957136

The ClinicalTrials.gov registry entry for NCT02957136 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Rapid respiratory pathogen nucleic acid amplification test is the first listed.

NCT02957136 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02957136 about?

NCT02957136 is a clinical study titled "Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department". This is a randomized clinical trial to assess the effect of rapid, near point-of-care testing for multiple common respiratory viruses and bacteria on antibiotic and anti-influenza medication use in emergency department (ED) patients with symptoms of influenza-like illness (ILI) and/or upper respirat...

What is the current status of trial NCT02957136?

This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2016-12-08. Estimated completion is 2018-04-30.

What interventions are being tested in trial NCT02957136?

The interventions under investigation include: Rapid respiratory pathogen nucleic acid amplification test (DEVICE).

Who is sponsoring clinical trial NCT02957136?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.